menu toggle

Podcast: Insulin biosimilars part 2

By AmerisourceBergen

In part two of a two-part series on insulin biosimilars, we’ll talk about how pharmacies can prepare to dispense biosimilars once these products receive interchangeability status.
You can also listen and subscribe wherever you get your podcasts, like Apple or Spotify.
Continue the conversation
Contact our biosimilars experts to learn more about our solutions for this important product category.
Topics:
Biosimilars Affordability Policy Pharmacy operations

Related Content

Podcast: Insulin biosimilars part 1

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2021
Insulin model texture

Manufacturers

Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2024
Vials

Manufacturers

Cost and resource burden of coverage with evidence development

victoria loo
Victoria Loo, MPH; Scott Shields, MBA
Cencora
November 2023
Cost and Resource Burden